Instructor: Dale Bredesen

No image available Biography: Dale E. Bredesen, M.D., received his undergraduate degree from Caltech  and  his  medical  degree from Duke.  He served as Resident and Chief Resident in Neurology at UCSF, then was postdoctoral fellow in the laboratory of Nobel laureate Prof. Stanley Prusiner.  He was a faculty member at UCLA from 1989-1994, then was recruited by the Burnham Institute to direct the Program on Aging.  In 1998 he became the Founding President and CEO of the Buck Institute for Research on Aging, and Adjunct Professor at UCSF; then in 2013 he returned to UCLA as the Director of the Easton Center for Alzheimer's Disease Research. The Bredesen Laboratory  studies  basic  mechanisms  underlying  the  neurodegenerative process, and the translation of this knowledge into effective therapeutics for Alzheimer's disease  and  other  neurodegenerative  conditions,  leading  to  the  publication  of  over  220 research papers. He established the ADDN (Alzheimer's Drug Development Network) with Dr. Varghese John in 2008, leading to the identification of new classes of therapeutics for Alzheimer's disease.  He  and  his  group  developed  a  new  approach  to  the  treatment  of Alzheimer's disease, and this approach led to the discovery of subtypes of Alzheimer's disease, followed by the first description of reversal of symptoms in patients with MCI and Alzheimer's disease, with the ReCODE (reversal of cognitive decline)protocol, published in 2014, 2016, and 2018.Dr. Bredesen is the author of the New York Times best sellers, The End of Alzheimer's and The End of Alzheimer's Program. His next book, The First Survivors of Alzheimer's, is in press for publication in August of 2021.

Classes by this instructor